Showing 1 - 20 results of 30 for search 'William J Muller', query time: 0.07s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Her-2 Breast Cancer Outcomes Are Mitigated by Consuming n-3 Polyunsaturated, Saturated, and Monounsaturated Fatty Acids Compared to n-6 Polyunsaturated Fatty Acids by Lyn M. Hillyer, Barbora Hucik, Enzo M. Baracuhy, Zhen Lin, William J. Muller, Lindsay E. Robinson, David W. L. Ma
Published 2020-12-01
Article -
11
Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer by Tung Bui, Jonathan Rennhack, Stephanie Mok, Chen Ling, Marco Perez, Joshua Roccamo, Eran R. Andrechek, Christopher Moraes, William J. Muller
Published 2019-10-01
Article -
12
-
13
Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer by Helen Creedon, Lucy A. Balderstone, Morwenna Muir, Jozef Balla, Laura Gomez-Cuadrado, Natasha Tracey, Joseph Loane, Teresa Klinowska, William J. Muller, Valerie G. Brunton
Published 2016-02-01
Article -
14
Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis by Meghan Morrison Joly, Michelle M. Williams, Donna J. Hicks, Bayley Jones, Violeta Sanchez, Christian D. Young, Dos D. Sarbassov, William J. Muller, Dana Brantley-Sieders, Rebecca S. Cook
Published 2017-06-01
Article -
15
Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient by Arghavan Alisoltani, Lacy M. Simons, Maria Francesca Reyes Agnes, Taylor A. Heald-Sargent, William J. Muller, Larry K. Kociolek, Judd F. Hultquist, Ramon Lorenzo-Redondo, Egon A. Ozer
Published 2023-10-01
Article -
16
CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis by Yi He, Marie-Anne Goyette, Jennifer Chapelle, Nadia Boufaied, Jalal Al Rahbani, Maribel Schonewolff, Eric I. Danek, William J. Muller, David P. Labbé, Jean-François Côté, Nathalie Lamarche-Vane
Published 2023-08-01
Article -
17
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program by Alison Hirukawa, Harvey W. Smith, Dongmei Zuo, Catherine R. Dufour, Paul Savage, Nicholas Bertos, Radia M. Johnson, Tung Bui, Guillaume Bourque, Mark Basik, Vincent Giguère, Morag Park, William J. Muller
Published 2018-06-01
Article -
18
Tetraspanin CD9 is Regulated by miR-518f-5p and Functions in Breast Cell Migration and In Vivo Tumor Growth by Danielle R. Bond, Richard Kahl, Joshua S. Brzozowski, Helen Jankowski, Crystal Naudin, Mamta Pariyar, Kelly A. Avery-Kiejda, Christopher J. Scarlett, Claude Boucheix, William J. Muller, Leonie K. Ashman, Murray J. Cairns, Séverine Roselli, Judith Weidenhofer
Published 2020-03-01
Article -
19
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer by Geneviève Deblois, Harvey W. Smith, Ingrid S. Tam, Simon-Pierre Gravel, Maxime Caron, Paul Savage, David P. Labbé, Louis R. Bégin, Michel L. Tremblay, Morag Park, Guillaume Bourque, Julie St-Pierre, William J. Muller, Vincent Giguère
Published 2016-07-01
Article -
20
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis by Li-Chung Tsao, Erika J. Crosby, Timothy N. Trotter, Junping Wei, Tao Wang, Xiao Yang, Amanda N. Summers, Gangjun Lei, Christopher A. Rabiola, Lewis A. Chodosh, William J. Muller, Herbert Kim Lyerly, Zachary C. Hartman
Published 2022-03-01
Article